罗恩 |
R029994-5mg |
5mg |
5~7个工作日 |
1071992-99-8 |
(5S,8S,10aR)-N-(二苯基甲基)十氢-5-[... AT406 (SM-406) |
99% |
468.00
468.00
|
|
J&K |
1564197-5MG |
5MG |
1-3天 |
1071992-99-8 |
AT 406拮抗剂 AT 406, 98%, a potent and or... |
98% |
585.00
585.00
|
|
J&K |
934734-25MG |
25MG |
4-6周 |
1071992-99-8 |
化合物AT406 Xevinapant, 98% |
98% |
1,999.00
1,999.00
|
|
J&K |
934734-5MG |
5MG |
4-6周 |
1071992-99-8 |
化合物AT406 Xevinapant, 98% |
98% |
664.00
664.00
|
|
J&K |
934734-10MG |
10MG |
4-6周 |
1071992-99-8 |
化合物AT406 Xevinapant, 98% |
98% |
928.00
928.00
|
|
阿拉丁 |
A126412-5mg |
5mg |
现货 |
1071992-99-8 |
AT406 (SM-406) AT406 (SM-406) |
Moligand™, ≥98% |
854.90
854.90
|
|
阿拉丁 |
A126412-10mg |
10mg |
现货 |
1071992-99-8 |
AT406 (SM-406) AT406 (SM-406) |
Moligand™, ≥98% |
1,411.90
1,411.90
|
|
阿拉丁 |
A126412-50mg |
50mg |
现货 |
1071992-99-8 |
AT406 (SM-406) AT406 (SM-406) |
Moligand™, ≥98% |
4,999.90
4,999.90
|
|
阿拉丁 |
A126412-25mg |
25mg |
现货 |
1071992-99-8 |
AT406 (SM-406) AT406 (SM-406) |
Moligand™, ≥98% |
2,872.90
2,872.90
|
|
阿拉丁 |
A126412-100mg |
100mg |
现货 |
1071992-99-8 |
AT406 (SM-406) AT406 (SM-406) |
Moligand™, ≥98% |
9,268.90
9,268.90
|
|
阿拉丁 |
X409188-1ml |
1ml |
现货 |
1071992-99-8 |
Xevinapant (AT406) Xevinapant (AT406) |
Moligand™, 10mM in DMSO |
1,083.92
1,083.92
|
|
毕得 |
BD305467-10mg |
10mg |
现货 |
1071992-99-8 |
(5S,8S,10aR)-N-二苯甲基-5-((S)-2... (5S,8S,10aR)-N-Benzhydryl-5-... |
98% |
685.00
685.00
|
|
毕得 |
BD305467-25mg |
25mg |
现货 |
1071992-99-8 |
(5S,8S,10aR)-N-二苯甲基-5-((S)-2... (5S,8S,10aR)-N-Benzhydryl-5-... |
98% |
1,371.00
1,371.00
|
|
毕得 |
BD305467-50mg |
50mg |
现货 |
1071992-99-8 |
(5S,8S,10aR)-N-二苯甲基-5-((S)-2... (5S,8S,10aR)-N-Benzhydryl-5-... |
98% |
2,330.00
2,330.00
|
|